华光新材: 华光新材第五届董事会独立董事专门会议2025年第二次会议决议

Core Points - The company held its second special meeting of the fifth board of independent directors on June 6, 2025, to discuss and approve various proposals related to a simplified procedure for issuing shares to specific targets [1][2][3] Group 1: Approval of Share Issuance - The independent directors unanimously agreed that the company meets the conditions for issuing shares through a simplified procedure to specific targets, in accordance with relevant laws and regulations [2][3] - The proposal for the company's simplified share issuance plan was approved, aligning with the company's long-term development strategy and protecting shareholder interests [2][3] - The independent directors approved the 2025 annual plan for issuing shares through a simplified procedure, confirming its feasibility and alignment with the interests of all shareholders, especially minority shareholders [2][3] Group 2: Fund Allocation and Analysis - The independent directors approved the proposal regarding the allocation of funds raised through the share issuance, emphasizing that the funds will be directed towards technology innovation, enhancing the company's tech attributes [3][4] - A detailed analysis report justifying the share issuance plan was approved, covering the background, necessity, pricing principles, and feasibility of the issuance [4] - The feasibility analysis report for the use of raised funds was also approved, confirming that the plan aligns with national industrial policies and the company's strategic development [4] Group 3: Risk Management and Shareholder Returns - The independent directors reviewed and approved the risk management measures related to the potential dilution of immediate returns from the share issuance, ensuring that the interests of all shareholders are protected [4][5] - A three-year dividend return plan for shareholders from 2025 to 2027 was approved, aligning with legal regulations and the company's actual situation [5] - The report on the usage of previously raised funds was approved, confirming compliance with regulations and accurate reporting of fund usage [5][6] Group 4: Non-Recurring Gains and Losses - The independent directors approved the detailed report on non-recurring gains and losses for the last three years and the first quarter of 2025, ensuring accurate reflection of the company's financial situation [6]